NYSE$UHT
Universal Health Realty Income Trust · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Reported a decrease in net income and FFO compared to the same period last year.
Universal Health Realty Income Trust reported a decrease in net income to $4.8 million, or $0.35 per diluted share, compared to $5.3 million, or $0.39 per diluted share in Q3 2021. FFO was $11.8 million, or $0.86 per diluted share, compared to $12.6 million, or $0.92 per diluted share in Q3 2021. The decrease in net income was primarily due to a vacant specialty hospital in Chicago and an increase in interest expense.
- Net income decreased by $496,000, or $0.04 per diluted share, compared to Q3 2021.
- FFO decreased by $816,000, or $0.06 per diluted share, compared to Q3 2021.
- The third quarter dividend of $0.71 per share, or $9.8 million in the aggregate, was declared on September 7, 2022 and paid on September 30, 2022.
- Construction of Sierra Medical Plaza I, an MOB located in Reno, Nevada, commenced in January 2022 and is anticipated to be completed and opened during the first quarter of 2023.
Headline financials
Revenue & EPS history
UHT · Revenue · Quarterly
$22.2M
Revenue by segment
UHT · $476K total across 2 segments · Q3 2022
- Other Revenue - UHS Facilities$255K+8.1%53.6%
- Other Revenue - Non-related parties$221K-21.1%46.4%
Forward guidance
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to the potential impact of COVID-19 on our financial results, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission, may cause the results to differ materially from those anticipated in the forward-looking statements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2022
-0.0%
Avg return
Earnings day
-0.2%
Avg return
5 days after
+1.0%
Avg return
30 days after
52%
34 / 65 earnings
Positive
+12.7%
Q1 2020
Best reaction
-6.8%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | -0.8% | — | |
| Q4 2025 | +0.2% | -0.7% | -9.7% | |
| Q3 2025 | +2.1% | +4.9% | +12.7% | |
| Q1 2025 | -0.5% | +1.7% | +2.2% | |
| Q4 2024 | +0.8% | +1.9% | +3.0% | |
| Q3 2024 | -2.9% | -4.6% | -2.2% | |
| Q2 2024 | +2.5% | +1.6% | +5.1% | |
| Q1 2024 | +0.8% | +5.8% | +10.1% | |
| Q4 2023 | +0.2% | -4.1% | -9.7% | |
| Q3 2023 | +1.1% | -0.9% | +3.4% | |
| Q2 2023 | -3.4% | -3.7% | -5.2% | |
| Q1 2023 | -5.9% | -6.5% | -8.3% | |
| Q4 2022 | -1.5% | -5.8% | -11.9% | |
| Q3 2022 | +5.3% | +8.8% | +15.6% | |
| Q2 2022 | +2.3% | +2.8% | -0.1% | |
| Q1 2022 | -3.1% | -11.1% | -7.3% | |
| Q4 2021 | +1.2% | +4.2% | +3.4% | |
| Q3 2021 | +0.5% | -0.6% | +2.2% | |
| Q2 2021 | -0.7% | -1.8% | -3.7% | |
| Q1 2021 | +0.2% | -3.0% | -0.0% | |
| Q4 2020 | -6.1% | -6.3% | +7.8% | |
| Q3 2020 | -2.3% | +2.7% | +14.5% | |
| Q2 2020 | +0.7% | +3.2% | -0.1% | |
| Q1 2020 | +12.7% | +9.9% | +5.9% | |
| Q4 2019 | -6.6% | -8.1% | -21.6% | |
| Q3 2019 | +3.7% | +8.4% | +0.7% | |
| Q2 2019 | +1.6% | +3.2% | +5.6% | |
| Q1 2019 | +3.8% | +3.7% | +8.0% | |
| Q4 2018 | +0.3% | +0.2% | +1.1% | |
| Q3 2018 | -6.8% | -11.2% | -6.2% | |
| Q2 2018 | +0.8% | +4.4% | +15.6% | |
| Q1 2018 | +4.1% | +2.0% | +3.1% | |
| Q4 2017 | +3.0% | +6.4% | +8.6% | |
| Q3 2017 | -0.8% | -2.9% | -0.2% | |
| Q2 2017 | -5.6% | -6.7% | -10.0% | |
| Q1 2017 | +0.3% | +0.9% | +3.0% | |
| Q4 2016 | -0.1% | -1.3% | +0.5% | |
| Q3 2016 | -4.1% | -5.8% | -0.3% | |
| Q2 2016 | -1.1% | +0.7% | +3.5% | |
| Q1 2016 | -1.5% | — | — | |
| Q4 2015 | +0.6% | — | — | |
| Q3 2015 | -0.1% | — | — | |
| Q2 2015 | +0.7% | — | — | |
| Q1 2015 | -2.3% | — | — | |
| Q4 2014 | -0.7% | — | — | |
| Q3 2014 | +1.4% | — | — | |
| Q2 2014 | -1.1% | — | — | |
| Q1 2014 | -0.2% | — | — | |
| Q4 2013 | +1.6% | — | — | |
| Q3 2013 | +1.9% | — | — | |
| Q2 2013 | -0.5% | — | — | |
| Q1 2013 | -1.9% | — | — | |
| Q1 2011 | -0.2% | — | — | |
| Q4 2012 | +1.7% | — | — | |
| Q3 2012 | -1.7% | — | — | |
| Q4 2011 | -1.0% | — | — | |
| Q2 2012 | -1.0% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -1.2% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +0.3% | — | — | |
| Q4 2010 | +0.3% | — | — | |
| Q2 2010 | +0.3% | — | — | |
| Q1 2010 | +4.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro